| CAS No. | 194423-15-9 |
|---|---|
| MDL No. | MFCD02179207 |
| MF | C17H13BrN4O |
| MW | 369.20 |
| InChI Key | HTUBKQUPEREOGA-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99+% | $23 | In Stock | |
| 2 mg | 99+% | $27 | In Stock | |
| 5 mg | 99+% | $31 | In Stock | |
| 10 mg | 99+% | $50 | In Stock | |
| 25 mg | 99+% | $97 | In Stock | |
| 50 mg | 99+% | $119 | In Stock | |
| 100 mg | 99+% | $120 | In Stock | |
| 250 mg | 99+% | $170 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
PD 168393 is a quinazoline with bromoanilino at position 4 and acrylamido at position 6. It functions as an epidermal growth factor receptor antagonist. It belongs to quinazolines, acrylamides, substituted anilines, bromobenzenes, and secondary carboxamides.
| CAS No. | 194423-15-9 |
|---|---|
| Product Name | Pd 168393 |
| Heavy Atom Count | 23 | Rotatable Bond Count | 4 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 4 | HBD | 2 |
| TPSA | 66.910 Ų | Charge | 0 |
| Exact Mass | 368.02727 | Complexity | 894.65 |
| pKa | 5.875 | XLogP | 4.260 |
